Localização do estoque

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Estoque sujeito a disponibilidade

Documentation

Baixar MSDS

Baixar COA de amostra

Inclui: HPLC, MASS/LC-MS, RMN de 1H, FT-IR, teor, Relatório de Elucidação Estrutural (SER) e dados analíticos adicionais dependendo do produto.

937-40-6N-Nitroso-N-methylbenzylamine (NBMA)(NMBzA)

● Em Estoque

Nº do catálogo:	VE006112
Nº CAS:	937-40-6
Fórmula Mol.::	C8H10N2O
Peso Mol.::	150.18 g/mol

Solicitar orçamento

Adicionar à lista de RFQ

Informações adicionais sobre o CAS 937-40-6

Fármaco de origem

Rivaroxaban

Nome IUPAC

N-Methyl-N-nitrosobenzenemethanamine

Sinônimos farmacopeicos

N/A

Outros sinônimos

Methylbenzylnitrosamine; N-benzyl-N-methylnitrous amide; Methyl-benzyl-nitrosoamin; Benzylamine, N-methyl-N-nitroso-; 1-Benzyl-1-methyl-2-oxohydrazine

SMILES

CN(CC1=CC=CC=C1)N=O

InChI

InChI=1S/C8H10N2O/c1-10(9-11)7-8-5-3-2-4-6-8/h2-6H,7H2,1H3

Condição de envio

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Dados adicionais de caracterização

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Descrição

N-Nitroso-N-methylbenzylamine is an N-nitroso derivative of the secondary amine present in Rivaroxaban | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Rivaroxaban production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Referências

Hsia, C. -C ., et al. ?Enhancement of Formation of the Esophageal Carcinogen Benzylmethylnitrosamine from Its Precursors by Candida Albicans.? Proceedings of the National Academy of Sciences, vol. 78, no. 3, Mar. 1981, pp. 1878?81, https://doi.org/10.1073/pnas.78.3.1878.?